Rosa's experience working in the lab and participating in the PCI Fellows program at Penn helped her gain valuable experience for her career at Deloitte.
Cell and Gene Therapy On Track to Hit Record Number of Regulatory Approvals; Potential Implications for Commercial Real Estate Industry
While the CGT industry is growing at a rapid rate, real estate development happens much slower, which may have implications for the amount of available space.
Penn Spinout REGENXBIO Inc. Enters Commercial Phase; Focuses Gene Therapy on Common Cause of Blindness
Regenxbio's gene therapy would eliminate the need for wet AMD patients to visit their doctor every few months to receive a needle in their eye to treat their condition.
School of Dental Medicine and School of Engineering and Applied Science Develop Hands-Free System to Brush and Floss Teeth Using Microrobots
In a proof-of-concept study, microrobots effectively cleaned plaque and decay-causing bacteria from both mock and human teeth.
Penn Engineering Professor Linh Thi Xuan Phan Joins NSF Project on Cyber-Physical Systems for Transportation Technology
A major goal of this research is to help self-driving cars and other autonomous transportation systems achieve increased efficiency and performance, as well as better safety guarantees.
Three Penn Medicine Innovation Projects Receive Clinical Care Innovation Grants from Independence Blue Cross
Learn about these cutting-edge new projects that are improving value-based medical care.
Penn Medicine ranked number two out of the top five large health systems, second only to Mayo Clinic in Rochester, MN.
Kelly is the CEO of Carisma Therapeutics, a PCI startup that provides cellular immunotherapy for solid tumors.
Learn about Marion Leary and her mission to help health professionals pursue a career path in innovation.
Philadelphia-based Cancer Research Institutions Receive over $700M in National Cancer Institute Grants from 2019 to 2021, Fourth-most in the Nation
The University of Pennsylvania led the region with 490 NCI grants totaling $234 million during this three year time period.